Magnus Unemo
Magnus Unemo is a prominent researcher at Örebro University in Sweden, known for his work on antimicrobial resistance in Neisseria gonorrhoeae. He contributed to the commentary accompanying a study on gepotidacin, emphasizing the potential for the drug to face resistance as well, and the need for ongoing development of additional treatments for gonorrhea.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Sweden | 1 | 7.00 | 0.08% | +0% | 10,099,265 | 7,605 | $530,000 | 399$ |
| Totals | 1 | 10,099,265 | 7,605 | $530,000 | 399$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Sweden:
Magnus Unemo is a professor at UCL in London and leads the work at the laboratory in Örebro.
7
Canada:
Magnus Unemo is a researcher who wrote in a Lancet editorial about the potential for N. gonorrhoeae to develop gepotidacin resistance.
6
United States:
Magnus Unemo is from Örebro University in Sweden and commented on the potential resistance of gonorrhea to gepotidacin.
5